Suppr超能文献

溶酶体β-半乳糖苷酶及其前体形式在正常和突变型人成纤维细胞中的免疫电子显微镜定位

Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts.

作者信息

Willemsen R, Hoogeveen A T, Sips H J, van Dongen J M, Galjaard H

出版信息

Eur J Cell Biol. 1986 Mar;40(1):9-15.

PMID:3084261
Abstract

Immunoelectron microscopy was performed to study the biosynthesis of lysosomal beta-galactosidase (beta-gal) in normal and mutant human fibroblasts. Using polyclonal and monoclonal antibodies we show in normal cells precursor forms of beta-gal in the rough endoplasmic reticulum (RER) and in the Golgi apparatus throughout the stack of cisternae. In the lysosomes virtually all beta-gal exists as a high molecular weight multimer of mature enzyme. In the autosomal recessive disease GM1-gangliosidosis caused by a beta-gal deficiency and in galactosialidosis, associated with a combined deficiency of lysosomal neuraminidase and beta-gal, precursor forms of the latter enzyme are found in RER, Golgi and some labeling is present at the cell surface. The lysosomes remain unlabeled, indicative for the absence of enzyme molecules in this organelle. In galactosialidosis fibroblasts also no mature beta-gal is found in the lysosomes but in these cells the presence of the monomeric form can be increased by leupeptin (inhibition of proteolysis) whereas addition of a partly purified 32 kDa "protective protein" results in the restoration of high molecular weight beta-gal multimers in the lysosomes.

摘要

进行免疫电子显微镜检查以研究正常和突变型人成纤维细胞中溶酶体β-半乳糖苷酶(β-半乳糖)的生物合成。使用多克隆抗体和单克隆抗体,我们在正常细胞中显示,在粗面内质网(RER)和整个高尔基池堆栈中的β-半乳糖前体形式。在溶酶体中,几乎所有的β-半乳糖都以成熟酶的高分子量多聚体形式存在。在由β-半乳糖缺乏引起的常染色体隐性疾病GM1-神经节苷脂沉积症以及与溶酶体神经氨酸酶和β-半乳糖联合缺乏相关的半乳糖唾液酸沉积症中,后一种酶的前体形式在RER、高尔基体中被发现,并且在细胞表面有一些标记。溶酶体未被标记,表明该细胞器中不存在酶分子。在半乳糖唾液酸沉积症成纤维细胞的溶酶体中也未发现成熟的β-半乳糖,但在这些细胞中,亮肽素(抑制蛋白水解)可增加单体形式的存在,而添加部分纯化的32 kDa“保护蛋白”可导致溶酶体中高分子量β-半乳糖多聚体的恢复。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验